Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs Rallybio Corporation (RLYB)
- Corbus Pharmaceuticals Holdings, Inc. CRBP 4.52 +4.39%
- Rallybio Corporation RLYB 16.28 −2.98%
Corbus Pharmaceuticals Holdings, Inc. and Rallybio Corporation are both Biotechnology companies. Corbus Pharmaceuticals Holdings, Inc. and Rallybio Corporation are of similar size ($89.1M and $83.8M). Corbus Pharmaceuticals Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 2.0×. Rallybio Corporation grew revenue faster over the last twelve months: 1.18% against −73.7%. Across the 14 metrics below, Rallybio Corporation leads on 10 and Corbus Pharmaceuticals Holdings, Inc. on 4.
Valuation
Profitability
| Metric | CRBP | RLYB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (95.58%) | 64.86% | (56.36%) |
| Return on assets | (80.85%) | 61.12% | (48.04%) |
| Return on invested capital | 0.00% | (1,052.03%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack